Tag

Speciality Ingredients

1 article

Sudeep Pharma FY26 Net Profit ₹174.3 Cr, Declares ₹1.50 Dividend

• Board approved audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026, with consolidated net profit of ₹174.28 crore. • Recommended a final dividend of ₹1.50 (150%)